Innate resistance to tuberculosis in man, cattle and laboratory animal models: Nipping disease in the bud?

Journal of Comparative Pathology

Volumn 151, Issue 4, 2014, Pages 291-308

  Cassidy, J P ^a   Martineau, A R ^b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bovine; Human; Innate immunity; Tuberculosis

Indexed keywords

CATHELICIDIN; CYTOKINE; LIPOCALIN; PATTERN RECOGNITION RECEPTOR; PEPTIDE; VITAMIN D;

ADAPTIVE IMMUNITY; BOVINAE; EXPERIMENTAL ANIMAL; GAMMA DELTA T LYMPHOCYTE; HOST RESISTANCE; HUMAN; INFECTION CONTROL; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; ANIMAL; BOVINE; DISEASE MODEL; DISEASE RESISTANCE; IMMUNOLOGY;

ANIMALIA; BOS; BOVINAE; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; HUMANS; TUBERCULOSIS;

EID: 84923183601     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2014.08.001     Document Type: Review

References (204)

1. Aderem A.A., Cohen D.S., Wright S.D., Cohn Z.A. Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. Journal of Experimental Medicine 1986, 164:165-179.
2. Aderem A.A., Scott W.A., Cohn Z.A. Evidence for sequential signals in the induction of the arachidonic acid cascade in macrophages. Journal of Experimental Medicine 1986, 163:139-154.
3. Aleman M., Schierloh P., de la Barrera S.S., Musella R.M., Saab M.A., et al. Mycobacterium tuberculosis triggers apoptosis in peripheral neutrophils involving toll-like receptor 2 and p38 mitogen protein kinase in tuberculosis patients. Infection and Immunity 2004, 72:5150-5158.
4. Allen A.R., Minozzi G., Glass E.J., Skuce R.A., McDowell S.W.J., et al. Bovine tuberculosis: the genetic basis of host susceptibility. Proceedings of the Royal Society B 2010, 277:2737-2745.
5. Alonso S., Pethe K., Russell D.G., Purdy G.E. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proceedings of the National Academy of Science USA 2007, 104:6031-6036.
6. Amanfu W. The situation of tuberculosis and tuberculosis control in animals of economic interest. Tuberculosis (Edinburgh) 2006, 86:330-335.
7. Ameni G., Aseffa A., Sirak A., Engers H., Young D.B., et al. Effect of skin testing and segregation on the prevalence of bovine tuberculosis, and molecular typing of Mycobacterium bovis in Ethiopia. Veterinary Record 2007, 161:782-786.
8. Anes E., Kühnel M.P., Bos E., Moniz-Pereira J., Habermann A., et al. Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nature Cell Biology 2003, 5:793-802.
9. Anonymous Human tuberculosis caused by Mycobacterium bovis - New York City, 2001-2004. Morbidity and Mortality Weekly Report 2005, 54:605-608.
10. Appelberg R., Gil Castro A., Gomes S., Pedrosa J., Silva M.T. Susceptibility of Beige mice to Mycobacterium avium: role of neutrophils. Infection and Immunology 1995, 63:3381-3387.
11. Arnedo-Pena A., Juan-Cerdán J.V., Romeu-Garcia A., Garcia-Ferrer D., Holguín-Gómez R., et al. Latent tuberculosis infection, tuberculin skin test and vitamin D status in contacts of tuberculosis patients: a cross-sectional and case-control study. BMC Infectious Diseases 2011, 11:349.
12. Awomoyi A., Marchant A., Howson J., McAdam K., Blackwell J., et al. Interleukin-10, polymorphism in SLC11A1 (formerlyNRAMP1), and susceptibility to tuberculosis. Journal of Infectious Disease 2002, 186:1808-1814.
13. Azad A.K., Sadee W., Schlesinger L.S. Innate immune gene polymorphisms in tuberculosis. Infection and Immunity 2012, 80:3343-3359.
14. Bacchetta J., Zaritsky J.J., Sea J.L., Chun R.F., Lisse T.S., et al. Suppression of iron-regulatory hepcidin by vitamin D. Journal of the American Society of Nephrology 2014, 25:564-572.
15. Bancroft G.J. The role of natural killer cells in innate resistance to infection. Current Opinion in Immunology 1993, 5:503-510.
16. Barrios-Payan J., Aguilar-León D., Lascurain-Ledezma R., Hernández-Pando R. Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis. Gaceta Médica de México 2006, 142:273-281.
17. Barthel R., Piedrahita J.A., McMurray D.N., Payeur J., Baca D., et al. Pathologic findings and association of Mycobacterium bovis infection with the bovine NRAMP1 gene in cattle from herds with naturally occurring tuberculosis. American Journal of Veterinary Research 2000, 61:1140-1144.
18. Basile J.I., Geffner L.J., Romero M.M., Balboa L., Sabio Y., García C., et al. Outbreaks of Mycobacterium tuberculosis MDR strains induce high IL-17 T-cell response in patients with MDR tuberculosis that is closely associated with high antigen load. Journal of Infectious Diseases 2011, 204:1054-1064.
19. Behar S.M., Divangahi M., Remold H.G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?. Nature Reviews of Microbiology 2010, 8:668-674.
20. Bellamy R. Susceptibility to mycobacterial infections: the importance of host genetics. Genes and Immunity 2003, 4:4-11.
21. Bellamy R., Ruwende C., Corrah T., McAdam K.P.W.J., Whittle H.C., et al. Assessment of the interleukin-1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tubercle and Lung Disease 1998, 79:83-89.
22. Bermingham M.L., Bishop S.C., Woolliams J.A., Pong-Wong R., Allen A.R., et al. Genome-wide association study identifies novel loci associated with resistance to bovine tuberculosis. Heredity 2014, 112:543-551.
23. Bermingham M.L., More S.J., Good M., Cromie A.R., Higgins I.M., et al. Genetics of tuberculosis in Irish Holstein-Friesian dairy herds. Journal of Dairy Science 2009, 92:3447-3456.
24. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
25. Bilal S., Iqbal M., Murphy P., Power J. Human bovine tuberculosis - remains in the differential. Journal of Medical Microbiology 2010, 59:1379-1382.
26. Bradfute S.B., Castillo E.F., Arko-Mensah J., Chauhan S., Jiang S., et al. Autophagy as an immune effector against tuberculosis. Current Opinion in Microbiology 2013, 16:355-365.
27. Braian C., Hogea V., Stendahl O. Mycobacterium tuberculosis-induced neutrophil extracellular traps activate human macrophages. Journal of Innate Immunity 2013, 5:591-602.
28. Brill K.J., Li Q., Larkin R., Canaday D.H., Kaplan D.R., et al. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infection and Immunity 2001, 69:1755-1765.
29. Brooks M.N., Rajaram M.V.S., Azad A.K., Amer A.O., Valdivia-Arenas M.A., et al. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiology 2011, 13:402-418.
30. Brotherstone S., White I.M.S., Coffey M., Downs S.H., Mitchell A.P., et al. Evidence of genetic resistance of cattle to infection with Mycobacterium bovis. Journal of Dairy Science 2010, 93:1234-1242.
31. Brown A.E., Holzer T.J., Andersen B.R. Capacity of human neutrophils to kill Mycobacterium tuberculosis. Journal of Infectious Diseases 1987, 156:985-989.
32. Campbell G.R., Spector S.A. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through theinduction of autophagy. PLoS Pathogens 2012, 8:e1002689.
33. Casanova J.L., Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annual Reviews in Immunology 2002, 20:581-620.
34. Cassidy J.P., Bryson T.D., Gutierrez Cancela M.M., Forster F., Pollock J.M., et al. Lymphocyte subsets in experimentally induced early-stage bovine tuberculous lesions. Journal of Comparative Pathology 2001, 124:46-51.
35. Cassidy J.P., Bryson T.D., Pollock J.M., Forster F., Evans R.T., et al. Early lesion formation in cattle experimentally infected with Mycobacterium bovis. Journal of Comparative Pathology 1998, 119:27-44.
36. Chan T.Y.K. Seasonal variation in vitamin-D status and the incidence of tuberculosis in different countries. Respiration 1999, 66:196.
37. Cobat A., Gallant C.J., Simkin L., Black G.F., Stanley K., et al. Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis. Journal of Experimental Medicine 2009, 206:2583-2591.
38. Cobat A., Hoal E.G., Gallant C.J., Simkin L., Black G.F., et al. Identification of a major locus, TNF1, that controls BCG-triggered tumor necrosis factor production by leukocytes in an area hyperendemic for tuberculosis. Clinical Infectious Diseases 2013, 57:963-970.
39. Comstock G.W. Epidemiology of tuberculosis. American Review of Respiratory Disease 1982, 125:8-15.
40. Cooper A.M., Mayer-Barber K.D., Sher A. Role of innate cytokines in mycobacterial infection. Mucosal Immunology 2011, 4:252-260.
41. Correia J.W., Freitas M.V., Queiroz J.A., Pereira Perrin M., Cavadas B. Interleukin-6 blood levels in sensitive and multiresistant tuberculosis. Infection 2009, 37:138-141.
42. Cosivi O., Grange J.M., Daborn C.J., Raviglione M.C., Fujikura T., et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerging Infectious Diseases 1998, 4:59-70.
43. Coussens A.K., Timms P.M., Boucher B.J., Venton T.R., Ashcroft A.T., et al. 1α,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009, 127:539-548.
44. Dannenberg A.M., Rook G.A. Pathogenesis of pulmonary tuberculosis: an interplay between tissue-damaging and macrophage-activating immune responses: dual mechanisms that control bacillary multiplication. Tuberculosis: Pathogenesis, Protection, and Control 1994, 459-484. ASM Press, Washington DC. B.R. Bloom (Ed.).
45. Davies P.D.O. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985, 66:301-306.
46. Dieli F., Sireci G., Caccamo N., Di Sano C., Titone L., et al. Selective depression of interferon-γ and granulysin production with increase of proliferative response by Vγ9/Vσ2 T cells in children with tuberculosis. Journal of Infectious Diseases 2002, 15:1835-1839.
47. Dieli F., Troye-Blomberg M., Ivanyi J., Fournie J.J., Bonneville M., et al. Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. European Journal of Immunology 2000, 30:1512-1519.
48. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., Deretic V. Toll-like receptors control autophagy. EMBO Journal 2008, 27:1110-1121.
49. Denis M., Keen D.L., Parlane N.A., Storset A.K., Buddle B.M. Bovine natural killer cells restrict the replication of Mycobacterium bovis in bovine macrophages and enhance IL-12 release by infected macrophages. Tuberculosis 2007, 87:53-62.
50. De Yang B., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. Journal of Experimental Medicine 2000, 192:1069-1074.
51. Divangahi M., Desjardins D., Nunes-Alves C., Remold H.G., Behar S.M. Eicosanoid pathways regulate adaptive immunity to. Mycobacterium tuberculosis. Nature Immunology 2010, 11:751-758.
52. Djoba Siawaya J.F., Beyers N., van Helden P., Walzl G. Differential cytokine secretion and early treatment response inpatients with pulmonary tuberculosis. Clinical and Experimental Immunology 2009, 156:69-77.
53. Douglas A.S., Strachan D.P., Maxwell J.D. Seasonality of tuberculosis: the reverse of other respiratory diseases in the UK. Thorax 1996, 51:944-946.
54. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. Journal of the American Medical Association 1999, 282:677-686.
55. Edwards D., Kirkpatrick C.H. The immunology of mycobacterial diseases. American Review of Respiratory Diseases 1986, 134:1062-1071.
56. Elass E., Aubry L., Masson M., Denys A., Guerardel Y., et al. Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism. Infection and Immunity 2005, 73:7064-7068.
57. Eruslanov E.B., Lyadova I.V., Kondratieva T.K., Majorov K.B., Scheglov I.V., et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infection and Immunity 2005, 73:1744-1753.
58. Eum S.Y., Kong J.H., Hong M.S., Lee Y.J., Kim J.H., et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary tuberculosis. Chest 2010, 137:122-128.
59. Ewer K., Millington K.A., Deeks J.J., Alvarez L., Bryant G., et al. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. American Journal of Respiratory Critical Care Medicine 2006, 174:831-839.
60. Fabri M., Stenger S., Shin D.M., Yuk J.M., Liu P.T., et al. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Science Translational Medicine 2011, 3:104ra102.
61. Feau S., Facchinetti V., Granucci F., Citterio S., Jarrossay D., et al. Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood 2005, 105:697-702.
62. Feng C.G., Kaviratne M., Rothfuchs A.G., Cheever A., Hieny S., et al. NK cell-derived IFN-γ differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. Journal of Immunology 2006, 177:7086-7093.
63. Flynn J.L., Chan J., Lin P.L. Macrophages and control of granulomatous inflammation in tuberculosis. Nature Immunology 2011, 4:271-278.
64. Forbes J.R., Gros P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 2003, 102:1884-1892.
65. Forrest K.Y.Z., Stuhldreher W.L. Prevalence and correlates of vitamin D deficiency in US adults. Nutrition Research 2011, 31:48-54.
66. Galligan C., Yoshimura T. Phenotypic and functional changes of cytokine-activated neutrophils. Chemical Immunology and Allergy 2003, 83:24-44.
67. Gan H., He X., Duan L., Mirabile-Levens E., Kornfeld H., et al. Enhancement of antimycobacterial activity of macrophages by stabilization of inner mitochondrial membrane potential. Journal of Infectious Disease 2005, 191:1292-1300.
68. Gandotra S., Jang S., Murray P.J., Salgame P., Ehrt S. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infection and Immunity 2007, 75:5127-5134.
69. Ganmaa D., Giovannucci E., Bloom B.R., Fawzi W., Burr W., et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. American Journal of Clinical Nutrition 2012, 96:391-396.
70. Gibney K.B., MacGregor L., Leder K., Torresi J., Marshall C., et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from Sub-Saharan Africa. Clinical Infectious Diseases 2008, 46:443-446.
71. Good M., Duignan A. An evaluation of the Irish single reactor breakdown protocol for 2005-2008 inclusive and its potential application as a monitor of tuberculin test performance. Veterinary Microbiology 2011, 151:85-90.
72. Gordon B., Cashman W.M. Tuberculosis in workers after residence in a tuberculosis hospital. Journal of the American Medical Association 1930, 94:1643-1645.
73. Green M. Cod liver oil and tuberculosis. British Medical Journal 2011, 343:d7505.
74. Griffin J.P., Harshan K.V., Born W.K., Orme I.M. Kinetics of accumulation of γδ receptor-bearing T lymphocytes in mice infected with live mycobacteria. Infection and Immunity 1992, 59:4263-4265.
75. Gros P., Skamene E., Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. Journal of Immunology 1981, 127:2417-2421.
76. Grzybowski S., Barnett G.D., Styblo K. Contacts of cases of active pulmonary tuberculosis. Bulletin of the International Union against Tuberculosis 1975, 50:90-106.
77. Gutierrez M.G., Gonzalez A.P., Anes E., Griffiths G. Role of lipids in killing mycobacteria by macrophages: evidence for NF-κB-dependent and -independent killing induced by different lipids. Cellular Microbiology 2009, 11:406-420.
78. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
79. Hackam D.J., Rotstein O.D., Zhang W., Gruenheid S., Gros P., et al. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. Journal of Experimental Medicine 1998, 188:351-364.
80. He X.N., Su F., Lou Z.Z., Jia W.Z., Song Y.L., et al. Ipr1 gene mediates RAW 264.7 macrophage cell line resistance to Mycobacterium bovis. Scandinavian Journal of Immunology 2011, 74:438-444.
81. Heldwein K.A., Liang M.D., Andresen T.K., Thomas K.E., Marty A.M., et al. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. Journal of Leukocyte Biology 2003, 74:277-286.
82. Hmama Z., Sendide K., Talal A., Garcia R., Dobos K., et al. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1, 25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. Journal of Cell Science 2004, 117:2131-2140.
83. Holscher C., Reiling N., Schaible U.E., Holscher A., Bathmann C., et al. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. European Journal of Immunology 2008, 38:680-694.
84. Hope J.C., Sopp P., Howard C.J. NK-like CD8+ cells in immunologically naïve neonatal calves that respond to dendritic cells infected with Mycobacterium bovis BCG. Journal of Leukocyte Biology 2002, 71:184-194.
85. Hope J.C., Thom M.L., McCormick P.A., Howard C.J. Interaction of antigen presenting cells with mycobacteria. Veterinary Immunology and Immunopathology 2004, 100:187-195.
86. Horsburgh C.R. Priorities for the treatment of latent tuberculosis infection in the United States. New England Journal of Medicine 2004, 350:2060-2067.
87. Hoshino Y., Hoshino S., Gold J.A., Raju B., Prabhakar S., et al. Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis. Journal of Infectious Disease 2007, 195:1303-1310.
88. Intemann C.D., Thye T., Niemann S., Browne E.N., Amanua Chinbuah M., et al. Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathogens 2009, 5:e1000577.
89. Israel H.L., Hetherington H.W., Ord J.G. A study of tuberculosis among students of nursing. Journal of the American Medical Association 1941, 117:839-844.
90. Janulionis E., Sofer C., Schwander S., Simmons D., Kreiswirth B., et al. Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity. Infection and Immunity 2005, 73:2595-2601.
91. Jurado J.O., Pasquinelli V., Alvarez I.B., Peña D., Rovetta A.I., et al. IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. Journal of Leukocyte Biology 2012, 91:991-1002.
92. Kaplan G.J., Fraser R.I., Comstock G.W. Tuberculosis in Alaska. American Review of Respiratory Disease 1970, 105:920-926.
93. Keane J., Balcewicz-Sablinska M.K., Remold H.G., Chupp G.L., Meek B.B., et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infection and Immunity 1997, 65:298-304.
94. Keane J., Remold H.G., Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. Journal of Immunology 2000, 164:2016-2020.
95. Kennedy H.E., Welsh M.D., Bryson D.G., Cassidy J.P., Forster F.I., et al. Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1+ γδ T cells. Infection and Immunity 2002, 70:1488-1500.
96. Khor C.C., Chapman S.J., Vannberg F.O., Dunne A., Murphy C., et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nature Genetics 2007, 39:523-528.
97. King K.Y., Lew J.D., Ha N.P., Lin J.S., Ma X., et al. Polymorphic allele of human IRGM1 is associated with susceptibility to tuberculosis in African Americans. PLoS ONE 2011, 6:e16317.
98. Kisich K.O., Higgins M., Diamond G., Heifets L. Tumor necrosis factor-α stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infection and Immunity 2002, 70:4591-4599.
99. Klingler K., Tchou-Wong K.-M., Brandli O., Aston C., Kim R., et al. Effects of mycobacteria on regulation of apoptosis in mononuclear phagocytes. Infection and Immunity 1997, 65:5272-5278.
100. Korbel D.S., Schneider B.E., Schaible U.E. Innate immunity in tuberculosis: myths and truth. Microbes and Infection 2008, 10:995-1004.
101. Lamont E.A., Janagama H.K., Riberio-Lima J., Vulchanova L., Seth M. Circulation Mycobacterium bovis peptides and host response proteins as biomarkers for unambiguous detection of subclinical infection. Journal of Clinical Microbiology 2014, 52:536-543.
102. Larcombe L.A., Orr P.H., Lodge A.M., Brown J.S., Dembinski I.J., et al. Functional gene polymorphisms in Canadian aboriginal populations with high rates of tuberculosis. Journal of Infectious Diseases 2008, 198:1175-1179.
103. Lertmemongkolchai G., Cai G., Hunter C.A., Bancroft G.J. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-γ in response to bacterial pathogens. Journal of Immunology 2001, 166:1097-1105.
104. Li Q., Whalen C.C., Albert J.M., Larkin R., Zukowski L., et al. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infection and Immunity 2002, 70:6489-6493.
105. Liebana E., Johnson L., Gough J., Durr P., Jahans K., et al. Pathology of naturally occurring bovine tuberculosis in England and Wales. Veterinary Journal 2008, 176:354-360.
106. Lima M.F., Kierszenbaum F. Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. Journal of Immunology 1985, 134:4176-4183.
107. Liu P., Stenger S., Li H., Wenzel L., Tan B., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
108. Lockhart E., Green A.M., Flynn J.L. IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. Journal of Immunology 2006, 177:4662-4669.
109. Lowe D.M., Bandara A.K., Packe G.E., Barker R.D., Wilkinson R.J., et al. Neutrophilia is common in tuberculosis and independently predicts case fatality. European Respiratory Journal 2013, 42:1752-1757.
110. Lowe D.M., Redford P.S., Wilkinson R.J., O'Garra A., Martineau A.R. Neutrophils in tuberculosis: friend or foe?. Trends in Immunology 2011, 33:14-25.
111. MacMicking J.D., Taylor G.A., McKinney J.D. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 2003, 302:654-659.
112. Magee D.A., Conlon K.M., Nalpas N.C., Browne J.A., Pirson C., et al. Innate cytokine profiling of bovine alveolar macrophages reveals commonalities and divergence in the response to Mycobacterium bovis and Mycobacterium tuberculosis infection. Tuberculosis 2014, 94:441-450.
113. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., et al. Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(h)1 priming. Nature Immunology 2004, 5:1260-1265.
114. Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. Journal of Steroid Biochemistry and Molecular Biology 2007, 103:793-798.
115. Martineau A.R., Leandro A.C.C.S., Anderson S.T., Newton S.M., Wilkinson K.A., et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. European Respiratory Journal 2010, 35:1106-1112.
116. Martineau A.R., Newton S.M., Wilkinson K.A., Kampmann B., Hall B.M., et al. Neutrophil-mediated innate immune resistance to mycobacteria. Journal of Clinical Investigation 2007, 117:1988-1994.
117. Martineau A.R., Wilkinson K.A., Newton S.M., Andres Floto R., Norman A.W., et al. IFN-γ and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-371. Journal of Immunology 2007, 178:7190-7198.
118. Martineau A.R., Wilkinson R.J., Wilkinson K.A., Newton S.M., Kampmann B., et al. A single dose of vitamin D enhances immunity to mycobacteria. American Journal of Respiratory Critical Care Medicine 2007, 176:208-213.
119. McGill J.L., Sacco R.E., Baldwin C.L., Telfer J.C., Palmer M.V., et al. Specific recognition of mycobacterial protein and peptide antigens by γδ T-cell subsets following infection with virulent Mycobacterium bovis. Journal of Immunology 2014, 192:2756-2769.
120. Meade K.G., Gormley E., Doyle M.B., Fitzsimons T., O'Farrelly C., et al. Innate gene repression associated with Mycobacterium bovis infection in cattle: toward a gene signature of disease. BMC Genomics 2007, 8:400.
121. Meraviglia S., El Daker S., Dieli F., Martini F., Martino A. γδ T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection. Clinical and Developmental Immunology 2011, 587315. 10.1155/2011/587315.
122. Millman A.C., Salman M., Dayaram Y.K., Connell N.D., Venketaraman V. Natural killer cells, glutathione, cytokines, and innate immunity against Mycobacterium tuberculosis. Journal of Interferon Cytokine Research 2008, 28:153-165.
123. Möller M., Hoal E.G. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 2010, 90:71-83.
124. Möller M., Nebel A., Kwiatkowski R., van Helden P.D., Hoal E.G., et al. Host susceptibility to tuberculosis: CARD15 polymorphisms in a South African population. Molecular and Cellular Probes 2007, 21:148-151.
125. Morrison W.I., Bourne F.J., Cox D.R., Donnelly C.A., Gettinby G., et al. Pathogenesis and diagnosis of infections with Mycobacterium bovis in cattle. Veterinary Record 2000, 146:236-242.
126. Murray P.J. Defining the requirements for immunological control of mycobacterial infections. Trends in Immunology 1997, 7:366-372.
127. Nardell E.A., Wallis R.S. Here today - gone tomorrow: the case for transient acute tuberculosis infection. American Journal of Respiratory and Critical Care Medicine 2006, 174:734-735.
128. Nelson C.D., Nonnecke B.J., Reinhardt T.A., Waters W.R., Beitz D.C., et al. Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3. PLoS ONE 2011, 6:e21674.
129. Nelson C.D., Reinhardt T.A., Thacker T.C., Beitz D.C., Lippolis J.D. Modulation of the bovine innate immune response by production of 1alpha, 25-dihydroxyvitamin D(3) in bovine monocytes. Journal of Dairy Science 2010, 93:1041-1049.
130. Netea M.G., Van der Meer J.W., Kullberg B.J. Toll-like receptors as an escape mechanism from the host defense. Trends in Microbiology 2004, 12:484-488.
131. Newton S.M., Smith R.J., Wilkinson K.A., Nicol M.P., Garton N.J., et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proceedings of the National Academy of Sciences of the USA 2006, 103:15594-15598.
132. Neyrolles O., Gicquel B., Quintana-Murci L. Towards a crucial role for DC-SIGN in tuberculosis and beyond. Trends in Microbiology 2006, 14:383-387.
133. North R.J., Jung Y.J. Immunity to tuberculosis. Annual Review of Immunology 2004, 22:599-623.
134. Orme I.M. A new unifying theory of the pathogenesis of tuberculosis. Tuberculosis 2014, 94:8-14.
135. Pan H., Yan B.S., Rojas M., Shebzukhov Y.V., Zhou H., et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005, 434:767-772.
136. Pedrosa J., Saunders B.M., Appelberg R., Orme I.M., Silva M.T., et al. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infection and Immunity 2000, 68:577-583.
137. Peng M.Y., Wang Z.H., Yao C.Y., Jiang L.N., Jin Q.L., et al. Interleukin 17-producing γδ T cells increased in patients with active pulmonary tuberculosis. Cellular and Molecular Immunology 2008, 5:203-208.
138. Perskvist N., Long M., Stendahl O., Zheng L. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. Journal of Immunology 2002, 168:6358-6365.
139. Piercy J., Werling D., Coffey T.J. Differential responses of bovine macrophages to infection with bovine specific and non-bovine specific mycobacteria. Tuberculosis 2007, 87:415-420.
140. Placido R.G., Mancino A., Amendola F., Mariani S., Vendetti M., et al. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. Journal of Pathology 1997, 181:31-38.
141. Pokkali S., Das S.D. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Human Immunology 2009, 70:110-115.
142. Pollock J.M., Pollock D.A., Campbell D.G., Girvin R.M., Crockard A.D., et al. Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle. Immunology 1996, 87:236-241.
143. Pollock J.M., Welsh M.D. The WC1+ γδ T-cell population in cattle: a possible role in resistance to intracellular infection. Veterinary Immunology and Immunopathology 2002, 89:105-114.
144. Price S., Davies M., Villarreal-Ramos B., Hope J. Differential distribution of WC1+ γδ TCR+ T lymphocyte subsets within lymphoid tissues of the head and respiratory tract and effects of intranasal M. bovis BCG vaccination. Veterinary Immunology and Immunopathology 2010, 136:133-137.
145. Price S.J., Sopp P., Howard C.J., Hope J.C. Workshop cluster 1+ γδ T-cell receptor T cells from calves expresshigh levels of interferon-γ in response to stimulation with interleukin-12 and -18. Immunology 2007, 120:57-65.
146. Purdy G.E., Russell D.G. Lysosomal ubiquitin and the demise of Mycobacterium tuberculosis. Cellular Microbiology 2007, 9:2768-2774.
147. Ramos-Kichik V., Mondragón-Flores R., Mondragón-Castelán M., Gonzalez-Pozos S., Muñiz-Hernandez S., et al. Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis 2009, 89:29-37.
148. Ratcliffe H.L., Palladino V.S. Tuberculosis induced by droplet nuclei infection. Journal of Experimental Medicine 1953, 97:61-67.
149. Reiling N., Holscher C., Fehrenbach A., Kroger S., Kirschning C.J., et al. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. Journal of Immunology 2002, 169:3480-3484.
150. Reiling N., Ehlers S., Hölscher C. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Immunology Letters 2008, 116:15-23.
151. Reis e Sousa C., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., et al. In-vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. Journal of Experimental Medicine 1997, 186:1819-1829.
152. Repasy T., Lee J., Marino S., Martinez N., Kirschner D.E., et al. Intracellular bacillary burden reflects a burst size for Mycobacterium tuberculosis invivo. PLoS Pathogens 2013, 9:e1003190.
153. Rhodes S.G., Terry L.A., Hope J., Hewinson R.G., Vordermeier H.M. 1, 25-dihydroxyvitamin D3 and development of tuberculosis in cattle. Clinical and Diagnostic Laboratory Immunology 2003, 10:1129-1135.
154. Rieder H.L. Epidemiologic basis of tuberculosis control. Proceedings of the International Union against Tuberculosis and Lung Disease 1999, Paris, p. 162.
155. Riol-Blanco L., Lazarevic V., Awasthi A., Mitsdoerffer M., Wilson B.S., et al. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. Journal of Immunology 2010, 184:1710-1720.
156. Rivas-Santiago B., Castaneda-Delgado J.E., Rivas Santiago C.E., Waldbrook M., Gonzalez-Curiel I., et al. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models. PLoS ONE 2013, 8:e59119.
157. Rivas-Santiago B., Serrano C.J., Enciso-Moreno J.A. Susceptibility to infectious diseases based on antimicrobial peptide production. Infection and Immunity 2009, 77:4690-4695.
158. Rivera-Marrero C., Stewart J., Shafer W., Roman J. The downregulation of cathepsin g in thp-1 monocytes after infection with Mycobacterium tuberculosis is associated with increased intracellular survival of bacilli. Infection and Immunity 2004, 72:5712-5721.
159. Rockett K.A., Brookes R., Udalova I., Vidal V., Hill A.V., et al. 1, 25-dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infection and Immunology 1998, 66:5314-5321.
160. Russell D.G., Sturgill-Koszycki S., Vanheyningen T., Collins H., Schaible U.E. Why intracellular parasitism need not be a degrading experience for Mycobacterium. Philosophical Transactions of the Royal Society B: Biological Science 1997, 352:1303-1310.
161. Saunders B., Frank A., Orme I., Cooper A. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infection and Immunology 2000, 68:3322-3326.
162. Saxena R.K., Weissman D., Simpson J., Lewis D.M. Murine model of BCG lung infection: dynamics of lymphocyte subpopulations in lung interstitium and tracheal lymph nodes. Journal of Biosciences 2002, 27:143-153.
163. Schmidtchen A. The multiple faces of host defence peptides and proteins. Journal of Innate Immunity 2012, 4:325-326.
164. Seiler P., Aichele P., Raupach B., Odermatt B., Steinhoff U., et al. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. Journal of Infectious Diseases 2000, 181:671-680.
165. Semple P.L., Watkins M., Davids V., Krensky A.M., Hanekom W.A., et al. Induction of granulysin and perforin cytolytic mediator expression in 10-week-old infants vaccinated with BCG at birth. Clinical and Developmental Immunology 2011, 438463. 10.1155/2011/438463.
166. Sharma S., Verma I., Khuller G.K. Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: invitro and exvivo study. European Respiratory Journal 2000, 16:112-117.
167. Shin D.-M., Yuk J.-M., Lee H.-M., Lee S.-H., Son J.W., et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cellular Microbiology 2010, 12:1648-1665.
168. Siddiqui N., Hope J. Differential recruitment and activation of natural killer cell sub-populations by Mycobacterium bovis-infected dendritic cells. European Journal of Immunology 2012, 43:159-169.
169. Siddiqui N., Price S., Hope J. BCG vaccination of neonatal calves: potential roles for innate immune cells in the induction of protective immunity. Comparative Immunology, Microbiology and Infectious Diseases 2012, 35:219-226.
170. Silva M.T., Silva M.N., Appelberg R. Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microbial Pathogenesis 1989, 6:369-380.
171. Singh S.B., Davis A.S., Taylor G.A., Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006, 313:1438-1441.
172. Sly L.M., Lopez M., Nauseef W.M., Reiner N.E. 1, 25-dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. Journal of Biological Chemistry 2001, 276:35482-35493.
173. Stead W.W., Senner J.W., Reddick W.T., Lofgren J.P. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. New England Journal of Medicine 1990, 322:422-427.
174. Stenger S., Hanson D.A., Teitelbaum R., Dewan P., Niazi K.R., et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998, 282:121-125.
175. Stern J.N., Keskin D.B., Romero V., Zuniga J., Encinales L., et al. Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after invitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunology Research 2009, 45:1-12.
176. Stockton J.C., Howson J.M., Awomoyi A.A., McAdam K.P., Blackwell J.M., et al. Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis. FEMS Immunology and Medical Microbiology 2004, 41:157-160.
177. Stoll S., Jonuleit H., Schmitt E., Muller G., Yamauchi H., et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. European Journal of Immunology 1998, 28:3231-3239.
178. Subbian S., Bandyopadhyay N., Tsenova L., O'Brien P., Khetani V., et al. Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits. Cell Communication and Signaling 2013, 11:60.
179. Sugawara I., Udagawa T., Yamada H. Rat neutrophils prevent the development of tuberculosis. Infection and Immunity 2004, 72:1804-1806.
180. Sugawara I., Yamada H., Hua S., Mizuno S. Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection. Microbiology and Immunology 2001, 45:743-750.
181. Sun L., Song Y., Riaz H., Yang H., Hua G., et al. Polymorphisms in toll-like receptor 1 and 9 genes and their association with tuberculosis susceptibility in Chinese Holstein cattle. Veterinary Immunology and Immunopathology 2012, 147:195-201.
182. Tailleux L., Maeda N., Nigou J., Gicquel B., Neyrolles O. How is the phagocyte lectin keyboard played ? Masterclass lesson by Mycobacterium tuberculosis. Trends in Microbiology 2003, 11:259-263.
183. Tan B.H., Meinken C., Bastian M., Bruns H., Legaspi A., et al. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. Journal of Immunology 2006, 177:1864-1871.
184. Thompson-Snipes L., Skamene E., Radzioch D. Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation. Infection and Immunity 1998, 66:5268-5274.
185. Ting J.P., Duncan J.A., Lei Y. How the non-inflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
186. Tsairidou S., Woolliams J.A., Allen A.R., Skuce R.A., McBride S.H., et al. Genomic prediction for tuberculosis resistance in dairy cattle. PLoS ONE 2014, 9:e96728.
187. Turner O.C., Basaraba R.J., Orme I.M. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infection and Immunity 2003, 71:864-871.
188. Vankayalapati R., Garg A., Porgador A., Griffith D.E., Klucar P., et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. Journal of Immunology 2005, 175:4611-4617.
189. Vordermeier M., Ameni G., Berg S., Bishop R., Robertson B.D., et al. The influence of cattle breed on susceptibility to bovine tuberculosis in Ethiopia. Comparative Immunology, Microbiology and Infectious Diseases 2012, 35:227-232.
190. Vordermeier M., Ameni G., Glass E.J. Cytokine responses of Holstein and Sahiwal zebu derived monocytes after mycobacterial infection. Tropical Animal Health Production 2012, 44:651-655.
191. Walzer T., Dalod M., Robbins S.H., Zitvogel L., Vivier E. Natural killer cells and dendritic cells: 'l'union fait la force'. Blood 2005, 106:2252-2258.
192. Wang J., Zhou X., Pana B., Yang L., Yin X., et al. Investigation of the effect of Mycobacterium bovis infection on bovine neutrophils functions. Tuberculosis 2013, 93:675-687.
193. Wang T.-T., Dabbas B., Laperriere D., Bitton A.J., Soualhine H., et al. Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of the NOD2/CARD15-defensinβ2 innate immune pathway defective in Crohn's disease. Journal of Biological Chemistry 2010, 285:2227-2231.
194. Watkins M.L., Semple P.L., Abel B., Hanekom W.A., Kaplan G., et al. Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response. Clinical and Vaccine Immunology 2008, 15:1666-1673.
195. Watson R.O., Manzanillo P.S., Cox J.S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012, 150:803-815.
196. Welsh M.D., Kennedy H.E., Smyth A.J., Girvin R.M., Andersen P., et al. Responses of bovine WC1+ γδ T cells to protein and non-protein antigens of Mycobacterium bovis. Infection and Immunity 2002, 70:6114-6120.
197. Werling D., Piercy J., Coffey T.J. Expression of TOLL-like receptors (TLR) by bovine antigen-presenting cells- potential role in pathogen discrimination?. Veterinary Immunology and Immunopathology 2006, 112:2-11.
198. Whelan A.O., Coad M., Cockle P.J., Hewinson G., Vordermeier M., et al. Revisiting host preference in the Mycobacterium tuberculosis complex: experimental infection shows M. tuberculosis H37Rv to be avirulent in cattle. PLoS One 2010, 5:e8527.
199. Widdison S., Watson M., Piercy J., Howard C., Coffey T.J. Granulocyte chemotactic properties of M. tuberculosis versus M. bovis-infected bovine alveolar macrophages. Molecular Immunology 2008, 45:740-749.
200. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000, 355:618-621.
201. Wilkinson R.J., Patel P., Llewelyn M., Hirsch C.S., Pasvol G., et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1® on tuberculosis. Journal of Experimental Medicine 1999, 189:1863-1874.
202. Yamada H., Mizumo S., Horai R., Iwakura Y., Sugawara I. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double knockout mice. Laboratory Investigation 2000, 80:759-767.
203. Yuhas Y., Azoulay-Alfaguter I., Berent E., Ashkenazi S. Rifampin inhibits prostaglandin E2 production and arachidonic acid release in human alveolar epithelial cells. Antimicrobial Agents and Chemotherapy 2007, 51:4225-4230.
204. Yuk J.-M., Shin D.-M., Lee H.-M., Yang C.-S., Jin H.-S., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host and Microbe 2009, 6:231-243.